Literature DB >> 27796679

Experiences among Women with Positive Prenatal Expanded Carrier Screening Results.

Erin Rothwell1,2, Erin Johnson3, Amber Mathiesen4, Kylie Golden3, Audrey Metcalf3, Nancy C Rose5, Jeffrey R Botkin6,5.   

Abstract

The offering and acceptance of expanded carrier screening is increasing among pregnant women including women without an increased risk based on race, ethnicity or family history. The chances of a positive screening test have been reported to be as high as 24 % when multiple conditions are screened. Yet, little is known about the way these tests are offered and how patients are affected by a positive test result. To explore this area of genetic testing, interviews (n = 17) were conducted among women who received positive expanded carrier results in the context of obstetric care. A content analysis was conducted on the transcript data from the interviews. Outcomes of this research suggest that educational interventions are needed to improve maternal understanding of positive carrier screening results. Most of the participants in this study confused the results with other prenatal screening test options. In addition, the way the results were discussed varied greatly, and influenced participants' thoughts about reproductive decisions that led to a range of emotional uncertainty. Our data suggests that genetic counseling improved participants' understanding of positive results. More research is needed to further understand if our results are consistent within a larger, more diverse sample, and to explore how to best provide education about expanded carrier screening.

Entities:  

Keywords:  Expanded carrier screening; Genetic counseling; Genetic testing; Positive results; Pregnancy

Mesh:

Year:  2016        PMID: 27796679      PMCID: PMC5432405          DOI: 10.1007/s10897-016-0037-8

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  13 in total

1.  Cystic fibrosis carrier screening in obstetric clinical practice: knowledge, practices, and barriers, a decade after publication of screening guidelines.

Authors:  Diana Darcy; Lu Tian; Joanne Taylor; Iris Schrijver
Journal:  Genet Test Mol Biomarkers       Date:  2011-03-31

2.  Promoting and evaluating scientific rigour in qualitative research.

Authors:  Lesley Baillie
Journal:  Nurs Stand       Date:  2015-07-15

3.  Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine.

Authors:  Janice G Edwards; Gerald Feldman; James Goldberg; Anthony R Gregg; Mary E Norton; Nancy C Rose; Adele Schneider; Katie Stoll; Ronald Wapner; Michael S Watson
Journal:  Obstet Gynecol       Date:  2015-03       Impact factor: 7.661

4.  Knowledge, attitudes, and barriers to carrier screening for the Ashkenazi Jewish panel: a Florida experience : Education and Barriers assessment for Jewish Genetic Diseases.

Authors:  Jessica R L Warsch; Sean Warsch; Elizabeth Herman; Lauren Zakarin; Adele Schneider; Jodi Hoffman; Deborah Wasserman; Deborah Barbouth
Journal:  J Community Genet       Date:  2014-01-12

5.  Assessing public attitudes on the retention and use of residual newborn screening blood samples: a focus group study.

Authors:  Erin Rothwell; Rebecca Anderson; Aaron Goldenberg; Michelle H Lewis; Louisa Stark; Matthew Burbank; Bob Wong; Jeffrey R Botkin
Journal:  Soc Sci Med       Date:  2012-02-18       Impact factor: 4.634

6.  What do patients prefer: informed consent models for genetic carrier testing.

Authors:  K E Ormond; M Iris; S Banuvar; J Minogue; G J Annas; S Elias
Journal:  J Genet Couns       Date:  2007-05-11       Impact factor: 2.537

7.  Teaching about cystic fibrosis carrier screening by using written and video information.

Authors:  E W Clayton; V L Hannig; J P Pfotenhauer; R A Parker; P W Campbell; J A Phillips
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

8.  An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals.

Authors:  Gabriel A Lazarin; Imran S Haque; Shivani Nazareth; Kevin Iori; A Scott Patterson; Jessica L Jacobson; John R Marshall; William K Seltzer; Pasquale Patrizio; Eric A Evans; Balaji S Srinivasan
Journal:  Genet Med       Date:  2012-09-13       Impact factor: 8.822

9.  Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research.

Authors:  Liane Ioannou; Belinda J McClaren; John Massie; Sharon Lewis; Sylvia A Metcalfe; Laura Forrest; Martin B Delatycki
Journal:  Genet Med       Date:  2013-09-12       Impact factor: 8.822

10.  ACMG position statement on prenatal/preconception expanded carrier screening.

Authors:  Wayne W Grody; Barry H Thompson; Anthony R Gregg; Lora H Bean; Kristin G Monaghan; Adele Schneider; Roger V Lebo
Journal:  Genet Med       Date:  2013-04-25       Impact factor: 8.822

View more
  19 in total

1.  An empirical assessment of the short-term impacts of a reading of Deborah Zoe Laufer's drama Informed Consent on attitudes and intentions to participate in genetic research.

Authors:  Erin Rothwell; Jeffrey R Botkin; Sydney Cheek-O'Donnell; Bob Wong; Gretchen A Case; Erin Johnson; Trent Matheson; Alena Wilson; Nicole R Robinson; Jared Rawlings; Brooke Horejsi; Ana Maria Lopez; Carrie L Byington
Journal:  AJOB Empir Bioeth       Date:  2018-04-06

2.  Genetic Counseling in the Era of Genomics: What's all the Fuss about?

Authors:  Gemma R Brett; Ella J Wilkins; Emma T Creed; Kirsty West; Anna Jarmolowicz; Giulia M Valente; Yael Prawer; Elly Lynch; Ivan Macciocca
Journal:  J Genet Couns       Date:  2018-01-24       Impact factor: 2.537

3.  Patient actions and reactions after receiving negative results from expanded carrier screening.

Authors:  S A Kraft; J L Schneider; M C Leo; T L Kauffman; J V Davis; K M Porter; C K McMullen; B S Wilfond; K A B Goddard
Journal:  Clin Genet       Date:  2018-03-13       Impact factor: 4.438

4.  Experiences and lessons learned by genetic counselors in returning secondary genetic findings to patients.

Authors:  Carly Rost; Karin M Dent; Jeffrey Botkin; Erin Rothwell
Journal:  J Genet Couns       Date:  2020-05-26       Impact factor: 2.537

5.  Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population.

Authors:  Inge B Mathijssen; Kim C A Holtkamp; Cecile P E Ottenheim; Janneke M C van Eeten-Nijman; Phillis Lakeman; Hanne Meijers-Heijboer; Merel C van Maarle; Lidewij Henneman
Journal:  Eur J Hum Genet       Date:  2018-01-10       Impact factor: 4.246

6.  Pre-implantation genetic testing: decisional factors to accept or decline among in vitro fertilization patients.

Authors:  Brandy Lamb; Erin Johnson; Leslie Francis; Melinda Fagan; Naomi Riches; Isabella Canada; Alena Wilson; Amber Mathiesen; Maya Sabatello; Shawn Gurtcheff; Erica Johnstone; Erin Rothwell
Journal:  J Assist Reprod Genet       Date:  2018-08-03       Impact factor: 3.412

7.  Should Clinicians Leave "Expanded" Carrier Screening Decisions to Patients?

Authors:  Amanda Fakih; Kayte Spector-Bagdady
Journal:  AMA J Ethics       Date:  2019-10-01

8.  Pregnant Women's Perspectives on Expanded Carrier Screening.

Authors:  Lauren Propst; Gwendolyn Connor; Megan Hinton; Tabitha Poorvu; Jeffrey Dungan
Journal:  J Genet Couns       Date:  2018-02-23       Impact factor: 2.537

9.  Assessing clinical education tools for expanded carrier screening.

Authors:  Chloe Dugger; Hannah S Anderson; Christine E Miller; Bob Wong; Erin P Johnson; Erin Rothwell
Journal:  J Genet Couns       Date:  2020-11-01       Impact factor: 2.537

10.  Evaluating the efficacy of three carrier screening workflows designed to identify at-risk carrier couples.

Authors:  Aishwarya Arjunan; Raul Torres; Anna Gardiner; Kristjan Eerik Kaseniit; Jeff Wootton; Rotem Ben-Shachar; Katherine Johansen Taber
Journal:  Prenat Diagn       Date:  2021-02-08       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.